BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 20472490)

  • 1. Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: no shortcuts on the road to approval.
    Breitbach CJ; Reid T; Burke J; Bell JC; Kirn DH
    Cytokine Growth Factor Rev; 2010; 21(2-3):85-9. PubMed ID: 20472490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double trouble for tumours: exploiting the tumour microenvironment to enhance anticancer effect of oncolytic viruses.
    De Silva N; Atkins H; Kirn DH; Bell JC; Breitbach CJ
    Cytokine Growth Factor Rev; 2010; 21(2-3):135-41. PubMed ID: 20338801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus combinations and chemotherapy for the treatment of human cancers.
    Kumar S; Gao L; Yeagy B; Reid T
    Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JX-594, a targeted oncolytic poxvirus for the treatment of cancer.
    Merrick AE; Ilett EJ; Melcher AA
    Curr Opin Investig Drugs; 2009 Dec; 10(12):1372-82. PubMed ID: 19943208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic viruses and histone deacetylase inhibitors--a multi-pronged strategy to target tumor cells.
    Nguyen TL; Wilson MG; Hiscott J
    Cytokine Growth Factor Rev; 2010; 21(2-3):153-9. PubMed ID: 20395162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emergence of combinatorial strategies in the development of RNA oncolytic virus therapies.
    Nguyen TL; Tumilasci VF; Singhroy D; Arguello M; Hiscott J
    Cell Microbiol; 2009 Jun; 11(6):889-97. PubMed ID: 19388908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiating oncolytic viruses by targeted drug intervention.
    Mahoney DJ; Stojdl DF
    Curr Opin Mol Ther; 2010 Aug; 12(4):394-402. PubMed ID: 20677090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of immunohistochemistry to determine oncolytic reovirus distribution and replication in-human tumors.
    Kapadia R; Coffey MC
    Methods; 2010 Dec; 52(4):301-6. PubMed ID: 20801221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.
    Sinkovics JG; Horvath JC
    Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic virotherapy of gynecologic malignancies.
    Hartkopf AD; Fehm T; Wallwiener D; Lauer U
    Gynecol Oncol; 2011 Feb; 120(2):302-10. PubMed ID: 21145097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel oncolytic viruses: riding high on the next wave?
    Stanford MM; Bell JC; Vähä-Koskela MJ
    Cytokine Growth Factor Rev; 2010; 21(2-3):177-83. PubMed ID: 20219409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting diversity: genetic approaches to creating highly potent and efficacious oncolytic viruses.
    Bauzon M; Hermiston TW
    Curr Opin Mol Ther; 2008 Aug; 10(4):350-5. PubMed ID: 18683099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. United virus: the oncolytic tag-team against cancer!
    Le Boeuf F; Bell JC
    Cytokine Growth Factor Rev; 2010; 21(2-3):205-11. PubMed ID: 20227326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in oncolytic viral therapy.
    Woo Y; Adusumilli PS; Fong Y
    Curr Opin Investig Drugs; 2006 Jun; 7(6):549-59. PubMed ID: 16784026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted and armed oncolytic poxviruses for cancer: the lead example of JX-594.
    Breitbach CJ; Thorne SH; Bell JC; Kirn DH
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1768-72. PubMed ID: 21740365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy progress and prospects cancer: oncolytic viruses.
    Liu TC; Kirn D
    Gene Ther; 2008 Jun; 15(12):877-84. PubMed ID: 18418413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress.
    Liu TC; Galanis E; Kirn D
    Nat Clin Pract Oncol; 2007 Feb; 4(2):101-17. PubMed ID: 17259931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic viral therapy using reovirus.
    Thirukkumaran C; Morris DG
    Methods Mol Biol; 2009; 542():607-34. PubMed ID: 19565924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naturally oncolytic viruses.
    Roberts MS; Lorence RM; Groene WS; Bamat MK
    Curr Opin Mol Ther; 2006 Aug; 8(4):314-21. PubMed ID: 16955694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting synergies between radiation and oncolytic viruses.
    Harrington KJ; Melcher A; Vassaux G; Pandha HS; Vile RG
    Curr Opin Mol Ther; 2008 Aug; 10(4):362-70. PubMed ID: 18683101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.